Abstract：
Recent innovations in digital technology have enabled the simultaneous accumulation, and the linking and analysis of time-series big data relating to several factors that influence blood pressure (BP), including biological indicators, physical activity, and environmental information. Various approaches can be used to monitor BP: in the office/clinic; at home; 24-h ambulatory recording; or with wearable and cuffless devices. Of these, home BP monitoring is a reliable and convenient method, and is recommended for hypertension management by current national and international guidelines. This recommendation is based on evidence showing that home BP is an important predictor of cardiovascular, cerebrovascular and kidney disease in patients with hypertension. In addition, lifetime personalized health record (PHR)-based home BP with telemonitoring combined with co-interventions has been shown to lower BP more effectively than the traditional approach based on office BP. Thus, home BP represents a key metric for personalized anticipation medicine, from digital healthcare to digital medicine. This paper summarizes the latest evidence on home BP monitoring and proposes a Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network consensus on a home BP-centered approach to the management of hypertension.
摘要：
数字技术的最新创新使同时积累，以及与影响血压（BP）的几个因素有关的时间序列大数据的链接和分析，包括生物指标，身体活动,和环境信息。可以使用各种方法来监测BP:在办公室/诊所;在家里;24小时动态记录;或使用可穿戴和无袖口设备。其中,家庭BP监测是一种可靠、方便的方法，并被当前的国家和国际指南推荐用于高血压管理。这项建议是基于证据表明家庭血压是心血管疾病的重要预测指标，高血压患者的脑血管和肾脏疾病。此外,基于终身个性化健康记录（PHR）的家庭BP与远程监测结合共同干预已被证明比基于办公室BP的传统方法更有效地降低BP。因此，家庭BP代表了个性化预测医学的关键指标，从数字医疗到数字医疗。本文总结了有关家庭BP监测的最新证据，并提出了亚洲高血压心血管结局预防和证据（HOPEAsia）网络关于以家庭BP为中心的高血压管理方法的共识。
